Makers Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹35.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.39 per cent from ₹34.17 crore. This corresponds to a year-on-year *(YoY) growth of 28.82 per cent.
Operating Profit
Operating Profit stands at ₹4.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.89 per cent from ₹2.28 crore. This corresponds to a year-on-year *(YoY) growth of 218.32 per cent.
PBDT
PBDT stands at ₹4.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 77.27 per cent from ₹2.42 crore. This corresponds to a year-on-year *(YoY) growth of 115.58 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.15 crore, reflecting a quarter-on-quarter *(QoQ) increase of 144.19 per cent from ₹1.29 crore. This corresponds to a year-on-year *(YoY) growth of 363.24 per cent.
Net Profit
Net Profit stands at ₹2.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 206.76 per cent from ₹0.74 crore. This represents a 740.74 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Makers Laboratories Ltd Earnings
- YOY
- QOQ
Makers Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Makers Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Makers Laboratories Ltd Financial Reports
Makers Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Makers Labs. | 0.13% | 3.26% | 3.80% | 8.36% | 19.31% | -3.24% |
| Concord Drugs | 0.00% | -3.78% | -3.31% | -3.38% | -7.09% | 151.32% |
| Pharmaids Pharma | -2.08% | -3.43% | -2.62% | -13.23% | -35.92% | -55.67% |
| Denis Chem Lab | -4.42% | -8.09% | -8.13% | -11.86% | -18.63% | -34.31% |
| Mercury Labs | 4.70% | -3.65% | 0.69% | -8.29% | -10.33% | -8.06% |
| Bacil Pharma | -0.09% | -1.50% | 0.90% | 27.92% | 72.21% | 37.06% |
| Bharat Immunolog | 0.40% | -8.67% | -3.07% | -7.11% | -13.88% | -28.65% |
Company Info
Company Information
Chairman & Independent Director : R K P Verma
Independent Non Exe. Director : Dipti Shah
Independent Non Exe. Director : Vishal Jain
Non-Executive & Non-Independent Director : Prashant Godha
Whole-time Director : Saahil U Parikh
Whole-time Director : Nilesh Jain
Company Sec. & Compli. Officer : Piyush Ajmera